ArticleFrontiers in stroke2024
More than a communication disorder: inequities in the financial toxicity of post-stroke aphasia.
Article in Frontiers in stroke, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- An Observational Examination of Circumlocution Ability in Acute Left-Hemisphere Stroke Survivors as a Possible Estimative Behavioral Measure of Very Mild Aphasia.Archives of physical medicine and rehabilitation · 2026Observational
- Validity and Reliability of the Turkish Version of the Communicative Effectiveness Index (CETI-TR) in Post-Stroke Aphasia.Brain and behavior · 2026Article
- Healthcare Access, Satisfaction, and Affordability: Experiences and Barriers of People with Aphasia.Aphasiology · 2025Article
- Treatment of aphasia in linguistically diverse populations: current and future directions.Frontiers in psychology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Aphasia, a communication disorder often resulting from stroke, can have profound impacts on both health outcomes and financial wellbeing. While the physical and cognitive consequences of stroke are well documented, the financial strain, or "financial toxicity," associated with managing chronic conditions like aphasia remains underexplored. Furthermore, financial toxicity is not experienced equally across racial and ethnic groups, with disparities driven by socioeconomic factors, access to healthcare, and structural inequities. This study compares the financial toxicity of people with aphasia (PWA) to those with stroke alone, examining differences across racial and ethnic groups to highlight disparities in economic burden. Methods: This study utilized data from the Medical Expenditure Panel Survey (MEPS) collected between 2018 and 2021 to examine the financial toxicity of PWA compared to those with stroke only. Financial toxicity was assessed using self-reported income and wealth data from the MEPS. Individual-level income and wealth values were calculated from the self-reported financial data to quantify the financial burden. Fixed effects regression models were employed to account for unobserved individual heterogeneity, controlling for time-invariant characteristics. Interaction terms were included in the models to capture the differential financial impacts of aphasia on Black and Hispanic individuals, compared to other racial and ethnic groups. The analysis examined both within-group and between-group differences in financial toxicity, highlighting potential racial and ethnic disparities among those affected by aphasia. Results: Approximately 18.71% ( Conclusion: This study showed the financial impact of post-stroke aphasia and the disparate burden among Black PWA. The findings highlight the need to address the financial ramifications of post-stroke morbidities such as aphasia among vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.